BCL2 and leukemia: For example, IL-6 is known to activate STAT3, a key transcription factor in leukemia, leading to the promotion of survival pathways, anti-apoptotic proteins (e.g., BCL-2), and pro-angiogenic factors, all of which contribute to the persistence of leukemia cells in the bone marrow.